News
02-05-2013, 01:16 AM
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced it has entered into an agreement to collaborate with Maimonides Medical Center to investigate the utility of Lymphoseek (technetium Tc 99m tilmanocept) Injection in lymphatic mapping procedures for colorectal cancer.
More... (http://www.news-medical.net/news/20130205/Maimonides-Navidea-to-evaluate-Lymphoseek-use-in-lymphatic-mapping-for-colorectal-cancer.aspx)
More... (http://www.news-medical.net/news/20130205/Maimonides-Navidea-to-evaluate-Lymphoseek-use-in-lymphatic-mapping-for-colorectal-cancer.aspx)